Skip to main content
FinSpry Logo
FinSpry
ELV logo
ELV
(NYSE)
Elevance Health, Inc.
$300.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Elevance Health, Inc. (ELV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Elevance Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$391.71
↑ 30.25% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ELV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ann Hynes
Mizuho
BuyMaintains
$413.00 → $350.00
David Macdonald
Truist
Strong BuyMaintains
$400.00 → $390.00
Lisa Gill
JP Morgan
BuyMaintains
$394.00 → $397.00
Andrew Mok
Barclays
BuyMaintains
$404.00 → $393.00
Stephen Baxter
Wells Fargo
BuyMaintains
$424.00 → $391.00
Jason Cassorla
Guggenheim
Strong BuyMaintains
$414.00 → $396.00
Jason Cassorla
Guggenheim
Strong BuyMaintains
$398.00 → $414.00
Justin Lake
Wolfe Research
BuyUpgrades
$425.00
Stephen Baxter
Wells Fargo
BuyMaintains
$403.00 → $424.00
Andrew Mok
Barclays
BuyMaintains
$385.00 → $404.00

Frequently Asked Questions

What is the analyst consensus rating for ELV?

The analyst consensus rating for ELV is "Buy" based on 7 analyst recommendations.

What is the average price target for ELV?

The average 12-month price target for ELV is $391.71, representing an upside of 30.2% from the current price of $300.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.